Patent Infringement Claims Dismissed For Failure To State A Claim Because An Affirmative Defense Applied

Mar 23, 2015

Reading Time : 1 min

The defendant moved to dismiss for failure to state a claim on the basis its activity was covered by the HatchWaxman Act’s safe harbor provision for clinical testing during the term of the patent. The plaintiff countered that the safe harbor was an affirmative defense and it was entitled to discovery to test the factual basis for the defense.

The court accepted that “generally an affirmative defense cannot serve as a basis for a [12(b)(6)] dismissal.” However, the court noted that if a complaint’s own allegations on the face of the complaint indicated the existence of an affirmative defense, dismissal could be proper under 12(b)(6). The court then likened the case before it to two other cases where the claims had been dismissed because the plaintiff had failed to allege any specific act of infringement not covered by safe harbor provisions. Finally, the court held dismissal of the infringement contentions was warranted because the plaintiff had only alleged the defendant used the patented technology in protected new drug investigational activity.

Enteris Biopharma, Inc. v. Clinical Pharmacology of Miami, Inc., No. 1­14­cv­227700­UU (Mar. 20, 2015) [Ungaro, J.].

Share This Insight

Categories

Previous Entries

IP Newsflash

December 5, 2025

District courts are split on whether a complaint can provide the required knowledge for post-suit indirect and willful infringement in that same lawsuit. Chief Judge Connolly in the District of Delaware recently confirmed that, consistent with his prior opinions, the complaint cannot serve as the basis for knowledge for either a claim of post-suit indirect infringement or a demand for willfulness-based enhanced damages in that lawsuit.

...

Read More

IP Newsflash

December 3, 2025

The Federal Circuit recently held that a patentee acted as its own lexicographer to define a claim term even though it did not explicitly define the term. Rather, because the patentee consistently and clearly used two terms interchangeably to describe the same structural feature and did so in all of the embodiments in which the feature appeared, the patentee impliedly gave the term its own, unique definition.

...

Read More

IP Newsflash

December 2, 2025

The Federal Circuit recently held an asserted patent was not entitled to its priority date because the priority application lacked written description support for the asserted claims. In so doing, the court explained that broad disclosures that do not provide reasonably specific support for narrower claims do not meet the written description requirement. The court also considered whether the inventor’s testimony showed they possessed the full scope of the claimed genus at the priority date or whether it was more likely the inventors first became aware of the claimed embodiments from public disclosures of the accused product.

...

Read More

IP Newsflash

December 1, 2025

In a Hatch-Waxman case, the District of Delaware denied a motion for summary judgment seeking to apply the ANDA filing date as the date of the hypothetical negotiation used to calculate reasonable royalty damages. Instead, the court determined that the appropriate date to use for the hypothetical negotiation is the launch date.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.